These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases]. Truong DD, Sczesni B, Fahn S, Gross J, Donovan K, van Bakel A, Wiley MK. Nervenarzt; 1988 Feb 18; 59(2):103-9. PubMed ID: 2896306 [No Abstract] [Full Text] [Related]
6. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia]. Schulte-Sasse U, Komar K, Eberlein HJ. Dtsch Med Wochenschr; 1985 Mar 22; 110(12):457-61. PubMed ID: 3979279 [Abstract] [Full Text] [Related]
7. [Pathophysiology and therapy of malignant neuroleptic syndrome]. Weller M, Kornhuber J. Nervenarzt; 1992 Nov 22; 63(11):645-55. PubMed ID: 1361662 [Abstract] [Full Text] [Related]
8. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison]. Schröder J, Linge C, Wähner A. Fortschr Neurol Psychiatr; 1988 Mar 22; 56(3):97-101. PubMed ID: 2896144 [Abstract] [Full Text] [Related]
10. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Addonizio G, Susman VL. J Clin Psychiatry; 1987 Mar 22; 48(3):102-5. PubMed ID: 2880837 [Abstract] [Full Text] [Related]
11. A case of clozapine-induced neuroleptic malignant syndrome. Miller DD, Sharafuddin MJ, Kathol RG. J Clin Psychiatry; 1991 Mar 22; 52(3):99-101. PubMed ID: 1672311 [Abstract] [Full Text] [Related]
12. Therapy of neuroleptic malignant syndrome. Lazarus A. Psychiatr Dev; 1986 Mar 22; 4(1):19-30. PubMed ID: 3703852 [Abstract] [Full Text] [Related]
13. Neuroleptic malignant syndrome. Levenson JL. Am J Psychiatry; 1985 Oct 22; 142(10):1137-45. PubMed ID: 2863986 [Abstract] [Full Text] [Related]
14. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome. Lee JW. J Clin Psychopharmacol; 2010 Feb 22; 30(1):3-10. PubMed ID: 20075641 [Abstract] [Full Text] [Related]
15. [Neuroleptic malignant syndrome. Case reports]. Berardi D, Troia M, Veronesi L, Ferrari G. Minerva Psichiatr; 1994 Dec 22; 35(4):199-219. PubMed ID: 7861943 [Abstract] [Full Text] [Related]
16. [Neuroleptic malignant syndrome]. Sczesni B, Schröder J, Becker H, Przuntek H. Wien Klin Wochenschr; 1991 Dec 22; 103(1):1-7. PubMed ID: 1673041 [Abstract] [Full Text] [Related]
17. A hazardous side effect of neuroleptics: diagnosis and treatment. Epperly TD, McGlaughlin VG, Leo KU. Geriatrics; 1990 Aug 22; 45(8):58-62. PubMed ID: 1974232 [Abstract] [Full Text] [Related]
18. [New findings and experiences in the field of malignant hyperthermia]. Schulte-Sasse U, Eberlein HJ. Anaesthesist; 1986 Jan 22; 35(1):1-9. PubMed ID: 2938519 [Abstract] [Full Text] [Related]
19. The evaluation and management of patients with neuroleptic malignant syndrome. Bhanushali MJ, Tuite PJ. Neurol Clin; 2004 May 22; 22(2):389-411. PubMed ID: 15062519 [Abstract] [Full Text] [Related]
20. Catatonia and neuroleptic malignant syndrome: two sides of a coin? Vancaester E, Santens P. Acta Neurol Belg; 2007 Jun 22; 107(2):47-50. PubMed ID: 17710840 [Abstract] [Full Text] [Related] Page: [Next] [New Search]